MedPath

PF-07940369

Generic Name
PF-07940369

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

Phase 1
Active, not recruiting
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2024-08-01
Last Posted Date
2024-11-04
Lead Sponsor
Pfizer
Target Recruit Count
18
Registration Number
NCT06532383
Locations
🇧🇪

Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

© Copyright 2025. All Rights Reserved by MedPath